X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Three Viruses That Pharma Sector Needs To Gear Up Against

Content Team by Content Team
23rd August 2022
in News, Research & Development
Three Viruses That Pharma Sector Needs To Gear Up Against

More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak of the Langya henipavirus in China also leaked. Researchers and public health officials are looking toward the future in an effort to predict what might trigger the next outbreak, even though COVID-19 is unlikely to be eradicated and the pandemic itself is not gone.

The main focus is on zoonotic viruses, including COVID-19’s causative agent, SARS-CoV-2. Zoonotic viruses start out in animals and then spread to humans through contact or mutation. Ebola, Zika, and West Nile viruses are a few examples. Around 10,000 viruses have the potential to infect people, according to a study published in April, and the majority are circulating stealthily in wild mammals. Cross-species viral transmission is more likely as a result of changing land use and climate.

All To Keep A Close Eye On: Coronaviruses, Filoviruses, And Flaviviruses

Three general categories of viruses are being closely examined by researchers. Coronaviruses come first. These include the SARS-CoV-2 virus as well as the SARS and MERS-causing viruses. The last two moved from animals to people, and SARS-CoV-2 most certainly did as well. Typically, coronaviruses in humans cause mild to severe upper respiratory tract illnesses, but as COVID-19, SARS, and MERS have shown, they are also capable of becoming fatal.

The second is Ebola, a virus in the filovirus family. Ebola, another zoonotic illness, is most likely spread by bats or monkeys to people. Hemorrhagic fevers are brought on by it, which can result in catastrophic internal bleeding. The Marburg virus is an additional member of this class.

The third is virus transmission by mosquitoes, particularly flaviviruses. These are additionally spread via ticks. They include ailments including yellow fever, dengue, and West Nile. Because they don’t travel from person to person, the possibility of a pandemic is reduced. They are only transferred by mosquitoes, and sadly, as the temperature rises, their range is expanding.

Previous Post

New Zealand Advances Alzheimers Drug Development Process

Next Post

Hanmi Reintroduces Liver Drug After Raising Bioavailability

Related Posts

SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Robots and AI in Drug
Articles

Robots and AI in Drug Discovery Are Transforming Medicine

29th May 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Next Post
Hanmi Reintroduces Liver Drug After Raising Bioavailability

Hanmi Reintroduces Liver Drug After Raising Bioavailability

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In